The pathology and diagnosis of cancer cachexia and a treatment insight from natural products: A review
- 27 April 2026
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1881 (4) , 189598
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (W2521063)
- National Natural Science Foundation of China (82374347)
- Shanghai Municipal Health Commission (2022QN005)
- Shanghai Municipal Health Commission (GWIV-28)
- Shanghai Municipal Health Commission (2024QN093)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (YD202216)
- Shanghai Municipal Human Resources and Social Security Bureau (2023PJD094)
- University of Hong Kong
- Science and Technology Commission of Shanghai Municipality (22ZR1462200)
This publication has 203 references indexed in Scilit:
- Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysisCancer Medicine, 2024
- Mirtazapine as Appetite Stimulant in Patients With Non–Small Cell Lung Cancer and AnorexiaJAMA Oncology, 2024
- Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshopJournal of Cachexia, Sarcopenia and Muscle, 2022
- Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.Journal of Cachexia, Sarcopenia and Muscle, 2020
- Olanzapine for the Treatment of Advanced Cancer–Related Chronic Nausea and/or VomitingJAMA Oncology, 2020
- Megestrol acetate for cachexia–anorexia syndrome. A systematic reviewJournal of Cachexia, Sarcopenia and Muscle, 2018
- Macrophage plasticity, polarization, and function in health and diseaseJournal of Cellular Physiology, 2018
- A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle, 2017
- Corticosteroid therapy of preterminal gastrointestinal cancerCancer, 1974